Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: drsvelte who wrote (3931)	5/5/1998 4:14:00 PM
From: Dauntless	Read Replies (1) \| Respond to of 7041

drsvelte - nothing yet... I'll check it out. This is just too painful <GGGGGG> !!!!!

To: drsvelte who wrote (3931)	5/5/1998 5:57:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Yes, I heard the news. There were two news items that relate. One is that the eye problems (i.e. seeing blue) as a side effect were evidenced in Viagra and certain subjects who already have certain eye problems were told to use the lowest dose of Viagra because of this side effect. This side effect was known a really long time ago: I read about it on the VVUS thread long before Viagra was approved. Also, someone guesting on CNBC said that Zonagen was a controversial company (he didn't say in what way) but had a very small market cap, a partnership with SGP, and was producing a drug "like" Viagra, so had the potential to double or triple. He didn't wsay in what period of time, but I figure it will double or triple in a month or two given the response. :-) Then, when it turns out that the drug is not even approved by the FDA, maybe the bottom will fall out, or maybe not even then. Who knows what new hype could drive it at any time. Linda